DON’T MISS
IamExpat FairIamExpat Job BoardIamExpat Webinars
Newsletters
EXPAT INFO
CAREER
HOUSING
EDUCATION
LIFESTYLE
EXPAT SERVICES
NEWS & ARTICLES
Home
Expat Info
German news & articles
EU approves single-dose Johnson & Johnson COVID-19 vaccine
Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy

EU approves single-dose Johnson & Johnson COVID-19 vaccine

Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy
or
follow us for regular updates:



Related Stories

Second Omicron booster jab gets green light from European Medicines AgencySecond Omicron booster jab gets green light from European Medicines Agency
Germany hopes new Novavax COVID jab might convince vaccine scepticsGermany hopes new Novavax COVID jab might convince vaccine sceptics
Confused about the COVID rules in your area? This app can helpConfused about the COVID rules in your area? This app can help
Germany puts 150 million euros into researching drugs to treat COVIDGermany puts 150 million euros into researching drugs to treat COVID
EU digital COVID certificate launches: What you need to knowEU digital COVID certificate launches: What you need to know
Germany's CureVac vaccine posts just 47 percent efficacyGermany's CureVac vaccine posts just 47 percent efficacy
Germany begins rollout of digital vaccine certificate: What you need to knowGermany begins rollout of digital vaccine certificate: What you need to know
June 2021: 7 changes affecting expats in GermanyJune 2021: 7 changes affecting expats in Germany
For expats of all colours, shapes and sizes

Explore
Expat infoCareerHousingEducationLifestyleExpat servicesNews & articles
About us
IamExpat MediaAdvertisePost a jobContact usImpressumSitemap
More IamExpat
IamExpat Job BoardIamExpat HousingIamExpat FairWebinarsNewsletters
Privacy
Terms of usePrivacy policyCookiesAvoiding scams

Never miss a thing!Sign up for expat events, news & offers, delivered once a week.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy


© 2025 IamExpat Media B.V.
© 2025 IamExpat Media B.V.
Mar 11, 2021
Abi Carter

Editor in chief at IamExpat Media

Abi studied German and History at the University of Manchester and has since lived in Berlin, Hamburg and Utrecht, working since 2017 as a writer, editor and content marketeer. Although she's happily taken on some German and Dutch quirks, she keeps a stash of Yorkshire Tea on hand, because nowhere does a brew quite like home.Read more

The European Medicines Agency (EMA) has approved the coronavirus vaccine developed by Johnson & Johnson for use in the EU. 

Johnson & Johnson vaccine receives EMA approval

The Johnson & Johnson vaccine is therefore the fourth coronavirus vaccine to be approved by the EMA in less than three months. The vaccine has proven to be 67 percent effective against preventing infection with COVID-19 after only two weeks, according to the Medicines Protection Board. 

Although this efficacy is lower than the vaccines already approved by the EMA, the major difference with the Johnson & Johnson vaccine is that it only requires one jab, as opposed to two. In clinical trials, the shot was shown to be 85 percent effective against serious symptoms of the virus (and therefore hospitalisation) after just one dose. 

Johnson & Johnson contracted to deliver 10,1 million doses to Germany in Q2

Like the AstraZeneca vaccine, it is also significantly easier to transport and store - and can therefore be administered by doctors in GP surgeries - as it does not need to be kept at sub-zero temperatures. 

The final decision on the conditional marketing authorisation of the vaccine now rests with the European Commission - although this step is largely considered a formality. It is likely to be waved through on Thursday. Germany already has a contract to receive 10,1 million doses of the Johnson & Johnson vaccine in the second quarter of 2021, and a further 26,6 million by the end of the year. 

By Abi Carter